PET brain scans could reveal hidden inflammation in patients with multiple sclerosis

A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs

Abbott’s neurostimulator recall, with 73 injuries reported, deemed Class I by FDA

Dive Brief: Abbott’s recall of its Proclaim and Infinity neurostimulation systems was categorized by the Food and Drug Administration as a Class I recall. Abbott contacted

September 14, 2023

Study links early-life tobacco exposure to accelerated aging, urging preventive action

A recent study in Science Advances found that early-life tobacco exposure, including in-utero and early smoking initiation, accelerates biological aging, emphasizing the importance of reducing

May 7, 2024

Public pharma is the best solution to the ongoing problem of drug shortages

Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.